BlackThorn Therapeutics, Inc.

Release Summary

BlackThorn Therapeutics today announced that it has closed a $14 million extension of its Series A financing, joined by GV (formerly Google Ventures) and Biomatics Capital.

BlackThorn Therapeutics, Inc.